Correlation Between Dyne Therapeutics and Genmab AS
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Genmab AS, you can compare the effects of market volatilities on Dyne Therapeutics and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Genmab AS.
Diversification Opportunities for Dyne Therapeutics and Genmab AS
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dyne and Genmab is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Genmab AS go up and down completely randomly.
Pair Corralation between Dyne Therapeutics and Genmab AS
Considering the 90-day investment horizon Dyne Therapeutics is expected to generate 3.0 times more return on investment than Genmab AS. However, Dyne Therapeutics is 3.0 times more volatile than Genmab AS. It trades about -0.05 of its potential returns per unit of risk. Genmab AS is currently generating about -0.28 per unit of risk. If you would invest 3,236 in Dyne Therapeutics on August 24, 2024 and sell it today you would lose (263.00) from holding Dyne Therapeutics or give up 8.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dyne Therapeutics vs. Genmab AS
Performance |
| Timeline |
| Dyne Therapeutics |
| Genmab AS |
Dyne Therapeutics and Genmab AS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyne Therapeutics and Genmab AS
The main advantage of trading using opposite Dyne Therapeutics and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.| Dyne Therapeutics vs. ZyVersa Therapeutics | Dyne Therapeutics vs. Sonnet Biotherapeutics Holdings | Dyne Therapeutics vs. Zura Bio Limited | Dyne Therapeutics vs. Phio Pharmaceuticals Corp |
| Genmab AS vs. ZyVersa Therapeutics | Genmab AS vs. Sonnet Biotherapeutics Holdings | Genmab AS vs. Zura Bio Limited | Genmab AS vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |